P. G. Casali

发表

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

M. Coleman, M. Piccart, V. Torri, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P. Casali, J. Blay, P. Casali, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, E. Álava, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.

P. Casali, P. Dileo, S. Ferrari, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

S. Sleijfer, S. Bonvalot, O. Mir, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.

P. Dileo, S. Ferrari, P. Picci, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, S. Bonvalot, O. Mir, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).

M. Piccart, K. Mcgregor, R. Stahel, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

J. Douillard, E. Cutsem, K. Fumasoli, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

I Judson, J Verweij, J. Blay, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

A. Llombart‐Bosch, A. D. Dei Tos, P. Casali, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma.

F. Grosso, P. Casali, P. Dileo, 2006, European journal of cancer.

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Litière, A. Cesne, H. Joensuu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P. G. Casali, P. Casali, J. Blay, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Rare cancers: from centralized referral to networking.

P. Casali, P. G. Casali, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Response to chemotherapy of solitary fibrous tumour: a retrospective study.

L. Mariani, A. D. Dei Tos, P. Casali, 2013, European journal of cancer.

Sunitinib malate in solitary fibrous tumor (SFT).

A. D. Dei Tos, P. Casali, T. Negri, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303

P. Navarria, P. Casali, L. Giordano, 2017, Annals of Surgical Oncology.

Sensitivity of well-differentiated/dedifferentiated liposarcoma (WD/DD) and myxoid round cell/liposarcoma (MRCL) to high-dose ifosfamide: Combined analysis from two European referral institutions.

P. Casali, I. Judson, S. Pilotti, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The sacral chordoma margin.

P. Georg, P. Navarria, D. Campanacci, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase II study on lapatinib in advanced EGFR-positive chordoma.

L. Mariani, P. Casali, T. Negri, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate.

H. Joensuu, P. Casali, C. Spreafico, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up.

P. Casali, S. Bielack, H. Jürgens, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS.

A. D. Dei Tos, P. Casali, A. Marrari, 2013, Hematology/oncology clinics of North America.

Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study.

A. Gronchi, C. Morosi, S. Stacchiotti, 2023, European journal of cancer.

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

P. A. Gardner, A. Caraceni, S. Boriani, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma

P. Casali, M. Pierotti, T. Negri, 2006 .

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

PALETTE: A randomized, double-blind, phase III trial of pazopanib versus placebo in patients (pts) with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy-An EORTC STBSG Global Network Study (EORTC 62072).

J. Blay, A. Cesne, A. D. Dei Tos, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas.

P. Casali, P. G. Casali, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution.

A. Gronchi, S. Stacchiotti, P. Collini, 2011, Annals of Oncology.

Is a stable disease according to RECIST criteria a real stable disease in GIST patients treated with imatinib mesylate (IM) included in the intergroup EORTC/ISG/AGITG trial?

J. Blay, J. Verweij, M. Glabbeke, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rare cancers: work in progress in Europe.

P. Casali, P. G. Casali, P. Casali, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].

P. Casali, N. Zaffaroni, M. Deraco, 2003, Tumori.

Quality of life assessment and clinical decision-making.

M. Costantini, P. Bruzzi, A. Santoro, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

DIGITAL SUPPORT FOR A HUB-AND-SPOKE DISEASE NETWORK

Paolo Locatelli, S. Provenzano, R. Sanfilippo, 2020, Proceedings of the 12th International Conference on e-Health (EH2020).

The activity of chemotherapy in inflammatory myofibroblastic tumour (IMT): a multicentre, European retrospective case series analysis.

L. Mariani, O. Mir, A. D. Dei Tos, 2020, The oncologist.

The Activity of Chemotherapy in In ﬂ ammatory Myo ﬁ broblastic Tumors: A Multicenter, European Retrospective Case Series Analysis

A. Cesne, A. Gronchi, C. Morosi, 2020 .